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BACKGROUND: The aim of this study was to examine the associations between urinary levels of the stress hor-
mones adrenaline, noradrenaline and cortisol during treatment with self reported stress, in order to investigate the
mechanism for the previously observed negative association of anxiety and depression with the outcome of
IVF/ICSI. METHODS: In a multicentre prospective cohort study, women entering their first cycle of IVF/ICSI
treatment were asked to participate. From each participant nocturnal urine samples were collected; pre-treatment,
before oocyte retrieval and before embryo-transfer (ET), to assess hormonal concentrations. Additionally, two
questionnaires were administered before the start of the treatment to measure anxiety and depression. RESULTS:
168 women completed the questionnaires and collected at least two urine specimens. A significant positive corre-
lation between urinary adrenaline concentrations at baseline and ET and the scores on depression at baseline were
found. In women with successful treatment, lower concentrations of adrenaline at oocyte retrieval and lower con-
centrations of adrenaline and noradrenaline at ET, compared with unsuccessful women, were found. CON-
CLUSIONS: The significant positive association of adrenaline concentration with pregnancy and with depression
suggested that this adrenal hormone could be one of the links in the complex relationship between
psychosocial stress and outcome after IVF/ICSI.
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Introduction
In vitro fertilization (IVF)/intra cytoplasmatic sperm injection
(ICSI) is a stressful experience and its outcome may be influ-
enced by many known and still unknown factors. In addition
to biomedical factors (such as age and history of pregnancy),
there is increasing evidence that psychological factors, for
instance anxiety and depression, are also related to IVF/ICSI
treatment outcome (Demyttenaere et al., 1998; Smeenk et al.,
2001). However, there are also studies in which no relation-
ship between the psychosocial status of women and treatment
outcome has been found (Boivin and Takefman, 1995; Slade
et al., 1997). This discrepancy may be explained by differ-
ences in population characteristics, study design and differ-
ences in the assessment of psychosocial factors.
In general, a distinction is made between direct and indir-
ect effects of stress. The direct effects refer to the effects
mediated by the autonomic nervous system, the (neuro) endo-
crine system and the immune system, whereas the indirect
effects imply those health changes resulting from changes in
health behaviour, for instance smoking. Modulation results in
an integrated adaptive psychobiological reaction pattern to
environmental challenges (Vingerhoets and Perski, 2000).
Although the effects of psychosocial stressors on the
activity of the sympathetic medullar system and on the hypo-
thalamic–pituitary–adrenal axis have been studied inten-
sively (Sanders and Bruce, 1997; Woods et al., 1998; Gold
et al., 2003; Schommer et al., 2003), no clear picture
emerges on the exact relationship between the different types
of stressors and release of stress hormones. Moreover, several
authors reported low correlation coefficients between ques-
tionnaire based and hormonal indicators of stress (Sanders
and Bruce, 1997; Woods et al., 1998).
So far, several reviews on stress and female reproduction
have been published (e.g. Greil, 1997; Magiakou et al., 1997;
Ferin, 1999; Dobson et al., 2003), but little is known about
the relationship between psychosocial stress and the release
of adrenal hormones in relation to IVF/ICSI treatment out-
come. As the treatment itself most probably influences psy-
chosocial factors, it is extremely difficult to separate cause
and effect of psychosocial factors on the outcome in IVF
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(Boivin and Takefman, 1995). The complex relationship is
mediated by an interplay of various systems; the underlying
mechanisms of the relationship remain obscure so far. Even
aspects of the treatment could influence the hormonal
response. For instance Luppa et al. (1995) found an increased
urinary excretion of cortisol metabolites after stimulation
with a GnRH agonist.
In an earlier study we demonstrated that pre-treatment
levels of anxiety and depression are significantly positively
related to treatment outcome in IVF/ICSI (Smeenk et al.,
2001). We hypothesized therefore, that pre-treatment levels
of anxiety and depression could be reflected in higher
concentrations of the stress hormones cortisol and catechol-
amines during treatment, which in turn could influence treat-
ment outcome.
The aim of the present study was therefore to examine the
association between the concentrations of the stress hormones
during treatment and the self-reported stress in order to
investigate the mechanism for the negative effect of anxiety
and depression on the outcome of IVF/ICSI.
Materials and methods
Participants
Patients visiting the outpatient clinic of the department of Obstetrics
and Gynaecology of the Radboud University, Nijmegen Medical
Centre an academic tertiary referral centre, or visiting the Amphia
hospital in Breda, a secondary referral centre, both in the Nether-
lands, were invited to participate in the study. They were scheduled
for the first IVF/ICSI treatment cycle between January 1999 and
March 2000. Details of the program and the protocol used have
been described previously (Smeenk et al., 2001).
Between day 10 and 20 of the pre-medication cycle, i.e. before
the start of GnRH-analogue administration (day 21), women were
asked to complete questionnaires on psychological factors. In
addition, the women were asked to provide urine samples. The first
urine sample was obtained before treatment, so before the start of
medication, at a random convenient day between day 10 and 20 of
the pre-medication cycle. This day was not necessarily the day that
the questionnaires were being filled out, but in the same period. The
other urine samples were taken before the time of oocyte retrieval
and before the embryo transfer (ET), two stressful moments during
treatment, as indicated by studies from Merari et al. (1992) and
Johnston et al. (1987).
Signed informed consent was obtained from all participants. This
study was approved by the ethical committees of the institutions.
All participants were guaranteed confidentiality, and only the princi-
pal investigator (J.S.) had full access to the questionnaires, concen-
trations of hormones in urine and the clinical data.
Sampling
Two psychological dimensions of stress were assessed in this study:
anxiety and depression. Anxiety was measured by means of the
Dutch version of the State Anxiety Inventory (STAI; Spielberger
et al., 1970). Depression was measured using the Dutch version of
the Beck Depression Inventory (BDI; Beck and Beamesderfer,
1974). Both questionnaires have shown satisfactory reliability and
validity.
For endocrine assessments three nocturnal urine samples were
collected. Initially, the urine sample was collected in a 2 litre
polypropylene bottle containing 5 ml of 6 mol/l HCl as preservatives
of the catecholamines to prevent oxidation; later we used sodium
disulfite (Na2S2O5) and Na2EDTA as preservatives to enable us to
measure cortisol in the same samples. Therefore, in the first 100
urine samples the concentration of cortisol could not be assessed.
Women were asked to collect all urine after midnight
(00.00 hours) including the first morning sample, at three timepoints
during their treatment cycle: T1: at baseline (before commencing
the IVF/ICSI treatment); T2: on the day of oocyte retrieval; and T3:
on the day of ET.
In the sample adrenaline, noradrenaline and cortisol levels were
measured and expressed per mmol of creatinine to correct for urine
sample size. Urinary creatinine concentrations were measured by a
modified Jaffé method on a Hitachi 747 analyzer (Boehringer
Mannhein, Germany).
Levels of adrenaline and noradrenaline were determined by
fluorometric determination after high performance liquid chromato-
graphy (HPLC). In short, catecholamines were extracted and sub-
sequently derivatized. The 2,3 diphenyl-quinoxaline derivatives of
adrenaline and noradrenaline were measured (Willemsen et al.,
1995). The inter-assay coefficient of variation for the noradrenalin
assay amounted to 4.2% (n ¼ 21) and 5.7% (n ¼ 17) at concen-
trations of 160 ^ 6.7 nmol/l and 403 ^ 22 nmol/l, respectively.
For adrenaline the coefficients of variation were 5.7% (n ¼ 21)
and 6.2% (n ¼ 17) at levels of 63.1 ^ 3.6 nmol/l and
67.4 ^ 4.2 nmol/l, respectively.
Free cortisol was measured by radioimmunoassay (RIA) after
extraction with dichloromethane and subsequent paper chromato-
graphy, according to the method described earlier for cortisol
measurement in plasma and saliva (Meulenberg et al., 1987). To
adapt this method for urinary assessment, [3H]cortisol was added as
a recovery tracer to 0.1 ml of urine, before extraction by means of
dichloromethane.
Successful treatment was defined as treatment resulting in a
viable pregnancy, with a positive heartbeat on transvaginal ultra-
sound 5 weeks after ET.
Statistical analysis
Data analysis was performed by means of the SPSS-program (ver-
sion 11.0 for windows, SPSS inc., Chicago, IL). The Spearman cor-
relation coefficient was used to express the association between
psychological and hormonal measurements (two-tailed).The distri-
bution free Mann–Whitney test for two independent samples was
used to compare hormonal findings at the various moments during
treatment between pregnant and non-pregnant women (two-tailed).
The nonparametric two-way ANOVA by ranks, or Friedman test,
was used to detect a trend in the hormonal response during treat-
ment (two-tailed).
Results
A total of 246 out of 291 participants (85%) returned the
questionnaires and were willing to collect urine specimens.
The remaining 45 patients did not participate because of
hygienic or logistic reasons.
Only women for whom questionnaire data and at least two
urine specimens (T1 and T2) were available, were included
in the analysis. A dataset was obtained in 36 women (66% of
the participants) coming from Breda and 132 (69%) coming
from Nijmegen. The main reason for incomplete data was
that a number of women forgot to collect the urine the morn-
ing before oocyte retrieval. The samples of one participant
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were discarded from analysis since the levels of adrenaline
and noradrenaline at T1 showed extreme variation
(.1000%) compared with the levels at T2 and T3.
Unfortunately, the first 100 urine samples were acidified
directly after obtaining the sample and therefore the concen-
tration of cortisol could not be assessed. Consequently, the
sample size for cortisol is smaller than for the catecholamines
and the sample size varies over the various stages of
treatment.
Since no significant differences were found in anxiety
(P ¼ 0.40) and depression (P ¼ 0.29) scores, and between
adrenaline (P ¼ 0.24), noradrenaline (P ¼ 0.42) and cortisol
(P ¼ 0.09) concentrations in urine, between the participants
of the two participating centres, the statistical analyses were
based on the combined dataset of both cities, resulting in a
sample of 167 women (68% of all participants).
Table I shows characteristics on demographic and psycho-
logical variables of the participants.
The ongoing pregnancy rate after the cycle was 32%.
During treatment, 16% (n ¼ 27) of the participants did not
reach embryo transfer, due to cancellation by the patient,
poor response, ovarian hyperstimulation syndrome or total
fertilization failure. Women who forgot to collect urine
samples on T3 did not show statistically significant differ-
ences on demographic, psychological or outcome variables
compared with the women who did not forget to collect
urine. No statistically significant differences were found
between pregnant and non-pregnant women on age
(P ¼ 0.12), duration of infertility (P ¼ 0.73), anxiety
(P ¼ 0.28), depression (P ¼ 0.11), but also on the number of
follicles (P ¼ 0.25), number of oocytes (P ¼ 0.45) and num-
ber of embryos (P ¼ 0.07).
A large variation between subjects was found for each of
the hormones (Table II). Table III shows the correlation
between the State Anxiety Inventory and the Beck Depression
Inventory scores and endocrine variables. Depression scores
were positively associated with concentrations of hormones.
In particular, a significant positive association was found
between adrenaline pre-treatment (0.17) and at the time of
embryo transfer (0.25) and the pre-treatment findings on
depression. An association for anxiety with adrenaline was
found as well, although this did not reach statistical signifi-
cance. Furthermore, a significant association was found
between cortisol concentrations at T2 and the pre-treatment
findings on anxiety (0.20) and depression (0.18). Explora-
tively, these analyses were repeated in subgroups comparing
successfully (meaning pregnant), or unsuccessfully treated
women. The correlation coefficients were stable.
Next, hormonal levels between successfully and unsuccess-
fully treated women were compared. The figures show the
concentrations of stress hormones during the various stages
of treatment, in comparing pregnant and non pregnant
women. Box and whisker plots were used to present the data,
without displaying the outliers, which did not fit the scales of
the figures. The outliers were used in the statistical analyses.
Significantly higher levels of adrenaline at the time of oocyte
retrieval (Figure 1B) and embryo transfer (Figure 1C) and on
noradrenaline at the time of embryo transfer (Figure 2C)
were found in unsuccessfully versus successfully treated
women. No significant hormonal differences were found pre
treatment (Figures 1A and 2A). In addition, no significant
differences were found on cortisol (Figure 3A–C).
The concentration of adrenaline showed a downward trend
during treatment (Chi ¼ 10.51; P ¼ 0.005). In comparing
the different stages of treatment, significantly lower levels of
adrenaline were found at T3 in comparison with T1
(Z ¼ 22.2; P ¼ 0.03) and T2 (Z ¼ 22.5; P ¼ 0.01). No
significant changes were found for the concentrations of nor-
adrenaline (Chi ¼ 0.68; P ¼ 0.71) or cortisol (Chi ¼ 0.56;
P ¼ 0.76) during treatment. No significant differences could
be observed between unsuccessfully versus successfully trea-
ted women with regard to the pattern of hormonal response
across treatment.
Discussion
The aim of the present study was to investigate the relation-
ship between pre-treatment psychological findings and
stress hormones during IVF/ICSI treatment. Additionally,
the hormonal levels at various stages of treatment were com-
pared between successfully and unsuccessfully treated
Table I. Demographic and psychological characteristics of the participants
(n ¼ 168)
Measure Mean SD Range Median
Age (years) 34.3 3.5 25–42 34
Duration of Infertility (years) 3.7 2.1 1–13 3
State anxiety score 36.6 9.1 20–61 36
BDI score 5.4 4.7 0–27 5
BDI, Beck Depression Inventory.
Table II. Characteristics of the hormonal measures (nmol/mmol of
creatinin)
Measure n Median Minimum Maximum SD
Adrenaline T1 167 0.82 0.25 6.49 0.89
Adrenaline T2 167 0.81 0.18 5.90 0.81
Adrenaline T3 83 0.72 0.07 4.63 0.84
Noradrenaline T1 167 15.98 0.97 40.00 6.54
Noradrenaline T2 167 15.62 0.24 44.87 6.87
Noradrenaline T3 83 15.52 0.99 40.19 6.67
Cortisol T1 120 3.50 0.08 30.48 4.24
Cortisol T2 129 2.92 0.06 12.50 2.96
Cortisol T3 68 3.18 0.04 36.36 5.45
Table III. Correlations of questionnaire findings and endocrine
measurements (nmol/mmol of creatinin) Spearman’s r
STAI-State BDI score
Adrenaline T1 0.12 (P ¼ 0.12) 0.17 (P ¼ 0.04)*
Adrenaline T2 0.14 (P ¼ 0.08) 0.14 (P ¼ 0.08)
Adrenaline T3 0.21 (P ¼ 0.06) 0.25 (P ¼ 0.02)*
Noradrenaline T1 0.06 (P ¼ 0.56) 0.09 (P ¼ 0.28)
Noradrenaline T2 0.03 (P ¼ 0.74) 0.01 (P ¼ 0.86)
Noradrenaline T3 0.11 (P ¼ 0.34) 0.16 (P ¼ 0.14)
Cortisol T1 0.06 (P ¼ 0.52) 0.13 (P ¼ 0.16)
Cortisol T2 0.20 (P ¼ 0.02)* 0.18 (P ¼ 0.04)*
Cortisol T3 20.08 (P ¼ 0.52) 20.10 (P ¼ 0.42)
*Observation significant at P , 0.05.
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women. Furthermore, the hormonal response during treat-
ment was assessed.
A positive association between adrenaline levels during
treatment and scores on pre-treatment depression was found.
A similar, although not significant, association was found
between adrenaline and pre-treatment anxiety. Cortisol levels
at the time of oocyte retrieval were found to be associated
with pre-treatment anxiety and depression scores, whereas no
associations were found for noradrenaline. The correlation
coefficients between questionnaire based and hormonal
Figure 1. Adrenaline/creatinin (nmol/mmol of creatinin) during treatment, comparing pregnant and non-pregnant women.
Figure 2. Noradrenaline/creatinin during treatment, comparing pregnant and non-pregnant women.
Figure 3. Cortisol/creatinin during treatment, comparing pregnant and non-pregnant women.
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indicators of stress are comparable with those reported in
previous publications (Sanders and Bruce, 1997; Woods
et al., 1998).
There was a considerable inter-individual variation in
baseline values of the hormones in this study. In a previous
study, similar high variation in hormones were found and
these could not be explained by menstrual cycle, behavioural,
emotional or cognitive stress reactions (Hansen et al., 2001).
Overall, the concentration of adrenaline at the time of ET
was found to be significantly lower than the concentrations
of adrenaline at the time of oocyte retrieval or at baseline. A
remarkable finding in our study was that successful treatment
was associated with significantly lower levels of adrenaline
at the time of oocyte retrieval and ET and lower levels of
noradrenaline at the time of ET. The implantation phase
seems to be involved, as other treatment variables were not
found to differ between the outcome groups. Whether the
effect of adrenaline is direct or indirect, however, needs
further exploration. To our knowledge, no previous reports
on the effect of adrenaline on treatment outcome in IVF
exist.
The correlation of adrenaline concentrations with BDI was
higher than with STAI. This could be due to the fact that the
chronic nature of the threatening infertility was of more
importance than the acute state stress, related to the treatment
itself. During treatment a decrease in the concentration of
adrenaline was found, which could be explained by high
levels of anxiety in anticipation of treatment. No decrease
was found in the concentrations of the other stress hormones.
This finding is in contrast with Harlow et al. (1996) who
found an increase in cortisol during IVF-treatment. However,
some of the differences could be explained by the method-
ology. As most cortisol in blood is bound to a carrier protein,
whereas in urine it is unbound, assays measuring cortisol in
blood and urine are not necessarily measuring the same
thing.
In our study, the stress response during treatment did not
differ between women who became pregnant after treatment
and those who did not become pregnant. This finding
suggests that the response itself cannot account for the
observed difference in treatment outcome. Furthermore, in
this sample no differences were observed on pre-treatment
psychological measures between the two outcome groups,
possibly due to the smaller sample size.
Although the relationship between psychosocial stress and
infertility has been studied intensively, so far little is known
about the effects of catecholamines and cortisol on physio-
logical processes involved in reproduction. Studies encom-
passing both catecholamines and cortisol in this particular
field are extremely rare. Cortisol was studied far more often
over the years, thus resulting in more hypotheses.
Catecholamines may affect fertility by altering uterine
blood flow (Schenker et al., 1992). Cortisol, having immuno-
suppressant properties, may affect immunological conditions
needed for implantation. Furthermore, it was found that corti-
sol levels in follicular fluids in stimulated cycles were corre-
lated with oocyte maturity and in vitro fertilizability (Fateh
et al., 1989). A direct effect on granulosa cells affecting
steroidogenesis and an influence on oocyte quality was pro-
posed by Michael and Cooke (1994). However, in most
studies merely an association is presented, as in our study,
since optimal research is hardly possible under ‘in vivo’ cir-
cumstances in this field.
Recently, Lewicka et al. (2003) have shown that a higher
serum cortisol/follicular cortisol ratio was associated with
pregnancy. Csemiczky et al. (2000) found that infertile
women have elevated stress levels in terms of circulating
prolactin and cortisol levels compared to the fertile controls.
Stress was previously found to be associated with high
amounts of activated T cells and reduced implantation rates
in IVF-women (Gallinelli et al., 2001). Demyttenaere et al.
(1992) indicated that women with high anticipatory state
anxiety levels and high anticipatory cortisol concentrations
have lower pregnancy rates in IVF. Facchinetti et al. (1997)
demonstrated a negative correlation between stress suscepti-
bility and outcome of IVF. Furthermore, Demyttenaere et al.
(1991) suggested that personality dependent stress responses
are important for conception rates in stimulated cycles. On
the other hand, women undergoing IVF were found to
respond biophysically differently to psychosocial stressors
than controls (Lindheim et al., 1995).
A limitation of the study could be the possibly confound-
ing relation between ovarian and stress hormones. The
relation between ovarian hormones and the effect on cat-
echolamines and cortisol was only scarcely investigated so
far. Kerdelhue et al. (1997) concluded that the absence of
changes in the activity of the corticotrophic axis during the
hormonal stimulation of IVF suggests that there was no
major stress component associated with the stimulation
phase, although in this study cortisol wasn’t assessed. Luppa
et al. (1995) did find an increased urinary excretion of corti-
sol metabolites after stimulation with an GnRH agonist, but
only in women with polycystic ovarian syndrome, and not in
healthy premenopausal women. Hirshoren et al. (2002) found
that hormonal changes during the normal menstrual cycle
affect noradrenaline, although the correlations with ovarian
hormones were very small. Sanders and Bruce (1999) con-
cluded after studying hormonal and psychological measures
of stress, that menstrual cycle quality does not account for
the association between conception with more favourable
moods. Ferin (1999) stated in a review on stress and the
reproductive cycle that sex steroids may interact with both
central and peripheral substrates of stress, thereby possibly
modifying the hypothalamic–pituitary–adrenal axis.
Overall, hormonal treatment, and consequently the altered
ovarian hormones, influence hormonal stress responses. The
exact mechanism, however, remains unclear.
We conclude that anxiety and especially depression before
IVF/ICSI treatment were positively associated with
urine adrenaline levels during treatment. However, there was
a large overlap in levels of this hormone between success-
fully and unsuccessfully treated women, which limits
the applicability in daily clinical practice. A drop in adrena-
line concentrations at the time of ET was found. Lower con-
centrations of adrenaline at the time of oocyte retrieval and
ET and lower levels of noradrenaline at the time of ET were
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found in women with successful treatment. Adrenaline, there-
fore, might be an important factor in the complex relation-
ship between psychosocial stress and outcome after
IVF/ICSI.
We recommend that future studies relating stress to treat-
ment outcome, should encompass all known aspects of stress,
e.g. psychological aspects, the autonomic nervous system and
the (neuro) endocrine system.
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